Tom Koglman practices intellectual property law with an emphasis on patent and trade secret litigation. He has experience in a variety of fields, including chemical compositions, pharmaceuticals, biotechnology, and medical devices.
In 2016, Tom was a member of the trial team that achieved the record-breaking patent infringement verdict for Idenix Pharmaceuticals (a subsidiary of Merck & Co.), the largest infringement verdict in U.S. history. After a two-week trial, the jury ordered Gilead Sciences to pay $2.54 billion in damages for sales of sofosbuvir-based medicines, including Sovaldi and Harvoni, for its infringement of an Idenix patent related to the treatment of patients with hepatitis C virus (HCV) infection.
Prior to joining Jones Day, Tom served as a police officer for 12 years. He held various positions including patrol supervisor, patrol officer, and instructor. He was certified by the state of Ohio as a police academy instructor, firearms and use-of-force instructor, evidence technician, armorer, and SWAT officer.
- Harvard University (J.D. 2015); Norwich University (B.A. in International Studies summa cum laude 1993)
- Ohio, U.S. District Courts for the Northern District of Ohio and Eastern District of Wisconsin, and U.S. Court of Appeals for the Federal Circuit
- Infantry Officer (Major), United States Marine Corps (1993-2009, active and reserve); Police Officer, City of North Ridgeville, Ohio (2000-2012)
- BTI Client Service All-Star (2022)